1.Surgical treatment of Giant Cell Tumor
Jung Hwan SON ; Jae Do KIM ; Young Chan SON ; Young Ki HONG ; Seong Hun YOUNG
The Journal of the Korean Orthopaedic Association 1994;29(3):1059-1065
Giant cell tumor is a predominantly benign condition but often the tumor is locally aggressive and tends to have high rate of recurrence and it can evolve into a malignant tumor. Thus the lesions have a practically difficult therapeutic problem for the orthopaedic surgeon and any method of treatment has not been satisfied. Between March 1984 and March 1993, clinical observation was carried out on 22 cases of giant cell tumor of bone to analyse the recurrence rate and functional evaluation of the joint according to the treatment methods, pathological grade and cortical destruction. The mean follow-up time was 75. 2 months. The recurrence rate of the intralesional excision group was 54.5% and that of the wide excision group was 9%, There was no relationship between the pathologic grade and recurrence rate. There was no recurrent case in the grade I cortical destruction but almost all of recurrence was occurred in the grade I or II cortical destruction. The functional result of the giant cell tumor occurred around the knee joint was that the mean ratings in the intralesional excision group were 79% and in the wide excision group were 51%. In conclusion, to achieve better joint function and less recurrence rate, intralesional or marginal excision with heat using bone cement or with chemical cauterization using phenol and alcohol can be used for cases of radiological grade I or II, and wide excision for grade III.
Cautery
;
Follow-Up Studies
;
Giant Cell Tumor of Bone
;
Giant Cell Tumors
;
Giant Cells
;
Hot Temperature
;
Joints
;
Knee Joint
;
Methods
;
Phenol
;
Recurrence
2.Membrane protein alterations associated with anticancer drug resistance in mouse lymphoblastic leukemia L1210 cells.
Seong Yong KIM ; Sung Kweon SON ; Jae Ryong KIM ; Jung Hye KIM
Yeungnam University Journal of Medicine 1993;10(2):432-444
Multidrug resistance(MDR) phenotype is frequently observed in animal and human cancer cell lines selected for in vitro resistance to a single chemotherapeutic agent. It is characterized by the diminished j drug accumulation and is related to the drug efflux mechanism in resistant cells. In the present study, adriamycin resistant cells(L1210-AdR6 : 10-6M adriamycin, -AdR5: 10-5M) and vincristine resistant cells (L1210-VcR7: 10-7M vincristine, -VcR6: 10-6M) were produced from mouse lymphoblastic leukemia cell line L1210. Growth profiles of survived cells were observed for 5 days with MTT(thiazolyl blue) assay and resistance was compared with IWdrug concentration of 50% survival reduction in absorbance). Resisrant cells proliferated more slowly than sensitive cell. Doubling times were 29.7hr in L1210, 68.7hr in L1210-AdR5 and 58.2hr in -VcR6. MDRs expressed as resistance factor were as follows, L1210-AdR5 was 76.4 times for vincristine, L1210-VcR6 was 96.4 times for adriamycin. The cell membrane proteins with three different M.W. were recognized to be related resistance, 220, 158, and 88 kd in L1210-AdR5, 158, 140 and 88 kd in L1210-VcR6 by SDS-PAG electrophoresis. Cell surface membrane proteins were identified by radio-iodination and autoradiogram. their molecular! weights were 158, 72.8. and 42.4 Kd in L1210-VcR6.
Animals
;
Cell Line
;
Doxorubicin
;
Drug Resistance*
;
Electrophoresis
;
Humans
;
Membrane Proteins*
;
Membranes*
;
Mice*
;
Phenotype
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma*
;
Vincristine
;
Weights and Measures
3.A Case of Single Coronary Artery c Effort Angina.
Yong Son JU ; In Whan SEONG ; Jae Joong KIM ; Seong Wook PARK ; Seung Jung PARK ; Jong Koo LEE
Korean Circulation Journal 1992;22(1):178-181
Single coronary artery is a rare congenital anomaly occurring in approximately 0.04% of the population. This entity can be diagnosed during life only by coronary angiography. Typical angina does not occur with single coronary artery in the absence of coexisting coronary artery disease or aortic stenosis. Among 874 patients who underwent diagnostic coronary angiography at Asan Medical Center. we have experienced a case of single coronary artery with significant atherosclerotic coronary artery disease which has been managed succesfully coronary angioplasty. We report this case of single coronary artery with a review of literature.
Angioplasty
;
Aortic Valve Stenosis
;
Chungcheongnam-do
;
Coronary Angiography
;
Coronary Artery Disease
;
Coronary Vessels*
;
Humans
4.A Case of Mucinous Cystadenoma of the Pancreas.
Myung Sik SUNG ; Jae Suk KIM ; Ji Won SON ; Seok Reyol CHOI ; Woo Won SHIN ; Jong Seong KIM
Korean Journal of Gastrointestinal Endoscopy 1992;12(1):71-74
The majority of the cysts developed in pancreas are inflammatory pseudocyst but neoplastic cysts are rarely encountered Especially, mucinous cystadenoma which was begun and originated from epithelial cell of pancreatic duct is difficult to differentiate from pseudocysts by preoperative clinical, laboratory and radiologic findings. Mucinous cystadenoma has a malignant potentiality, so complete excision of cystadenoma is the treatment of choice. Recently, we experienced one case of mucionus cystadenoma in 37 year-old female, we report it with a review of the literature.
Adult
;
Cystadenoma
;
Cystadenoma, Mucinous*
;
Epithelial Cells
;
Female
;
Humans
;
Mucins*
;
Pancreas*
;
Pancreatic Ducts
5.Comparison of partially-absorbable lightweight mesh with heavyweight mesh for inguinal hernia repair: multicenter randomized study.
Seong Dae LEE ; Taeil SON ; Jae Bum LEE ; Yeon Soo CHANG
Annals of Surgical Treatment and Research 2017;93(6):322-330
PURPOSE: Prosthetic mesh is widely used for inguinal hernia repair; however, pain and stiffness can develop. This study was a prospective, multicenter, single-blind, randomized trial to assess postoperative pain and quality of life according to mesh type after inguinal hernia repair. METHODS: Forty-seven patients who underwent Lichtenstein repair for unilateral inguinal hernia with prosthetic mesh were enrolled and randomly allocated to the partially-absorbable lightweight mesh (LW group, n = 24) or heavyweight mesh group (HW group, n = 23). Data were collected using a visual analogue scale (VAS), Carolinas Comfort Scale (CCS), and Activities Assessment Scale (AAS) at screening and postoperative day 1, 7, 90, and 120; foreign body sensation, sense of stiffness, and sense of pull during activity were also evaluated. RESULTS: There were no significant differences in patients' demographics and clinical characteristics between groups. The VAS at day 90 was significantly lower in the LW group (0.46 ± 0.78 vs. 0.96 ± 0.82, P = 0.027). The CCS and AAS were significantly lower in the LW group at day 1 (51.33 ± 20.29 vs. 64.65 ± 22.64, P = 0.047 and 39.83 ± 9.88 vs. 46.43 ± 7.82, P = 0.015, respectively). Foreign body sensation was significantly lower in the LW group at day 120 (4.2% vs. 30.4 %, P = 0.023), as was sense of stiffness (P = 0.023). The sense of pull during activity was lower in the LW group at day 90 and 120 (P = 0.012 and P = 0.022, respectively). There was no recurrence or serious complication during follow-up. CONCLUSION: Partially-absorbable lightweight prosthetic mesh can be used for inguinal hernia repair safely and improve functional outcomes and quality of life after surgery.
Demography
;
Follow-Up Studies
;
Foreign Bodies
;
Hernia, Inguinal*
;
Humans
;
Mass Screening
;
Pain, Postoperative
;
Prospective Studies
;
Quality of Life
;
Recurrence
;
Sensation
;
Surgical Mesh
6.Comparison of partially-absorbable lightweight mesh with heavyweight mesh for inguinal hernia repair: multicenter randomized study.
Seong Dae LEE ; Taeil SON ; Jae Bum LEE ; Yeon Soo CHANG
Annals of Surgical Treatment and Research 2017;93(6):322-330
PURPOSE: Prosthetic mesh is widely used for inguinal hernia repair; however, pain and stiffness can develop. This study was a prospective, multicenter, single-blind, randomized trial to assess postoperative pain and quality of life according to mesh type after inguinal hernia repair. METHODS: Forty-seven patients who underwent Lichtenstein repair for unilateral inguinal hernia with prosthetic mesh were enrolled and randomly allocated to the partially-absorbable lightweight mesh (LW group, n = 24) or heavyweight mesh group (HW group, n = 23). Data were collected using a visual analogue scale (VAS), Carolinas Comfort Scale (CCS), and Activities Assessment Scale (AAS) at screening and postoperative day 1, 7, 90, and 120; foreign body sensation, sense of stiffness, and sense of pull during activity were also evaluated. RESULTS: There were no significant differences in patients' demographics and clinical characteristics between groups. The VAS at day 90 was significantly lower in the LW group (0.46 ± 0.78 vs. 0.96 ± 0.82, P = 0.027). The CCS and AAS were significantly lower in the LW group at day 1 (51.33 ± 20.29 vs. 64.65 ± 22.64, P = 0.047 and 39.83 ± 9.88 vs. 46.43 ± 7.82, P = 0.015, respectively). Foreign body sensation was significantly lower in the LW group at day 120 (4.2% vs. 30.4 %, P = 0.023), as was sense of stiffness (P = 0.023). The sense of pull during activity was lower in the LW group at day 90 and 120 (P = 0.012 and P = 0.022, respectively). There was no recurrence or serious complication during follow-up. CONCLUSION: Partially-absorbable lightweight prosthetic mesh can be used for inguinal hernia repair safely and improve functional outcomes and quality of life after surgery.
Demography
;
Follow-Up Studies
;
Foreign Bodies
;
Hernia, Inguinal*
;
Humans
;
Mass Screening
;
Pain, Postoperative
;
Prospective Studies
;
Quality of Life
;
Recurrence
;
Sensation
;
Surgical Mesh
7.A Case of Cavernous Hemangioma of the Pyriform Sinus.
Han Kook LEE ; Seong Hwan SON ; Kang Dae LEE ; Jae Hwa LEE
Korean Journal of Otolaryngology - Head and Neck Surgery 2002;45(7):730-732
Approximately 60% of all hemangiomas occur in the head and neck region, but hypopharyngeal hemangiomas are very rare. The diagnoses were classified depending on histopathologic findings into cavernous hemangioma, capillary hemangioma and mixed hemangioma. The treatments are sclero theraphy, surgical excision, vascular ligation, cryotheraphy, electrical cautery, ND Yag laser excision, and CO2 laser excision. We have experienced a case of hemangioma in the medial wall of the left pyriform sinus. In our case, we removed it "en bloc" without difficulty with the endoscopic CO2 laser. The histologic diagnosis was a cavernous hemangioma with no evidence of malignancy. One year after surgery, there was no evidence of residual tumors or recurrence. We report this case of cavernous hemangioma in the hypopharynx.
Cautery
;
Diagnosis
;
Head
;
Hemangioma
;
Hemangioma, Capillary
;
Hemangioma, Cavernous*
;
Hypopharynx
;
Lasers, Gas
;
Lasers, Solid-State
;
Ligation
;
Neck
;
Neoplasm, Residual
;
Pyriform Sinus*
;
Recurrence
8.The effects of static magnetic field and pulsed electromagnetic field on alkaline phosphatase and dna synthetic activity of ME3t3-E1 cells.
Jeong Hee SON ; Seong Min BAE ; Jae Hyun SUNG
Korean Journal of Orthodontics 1997;27(4):623-632
The purpose of this study was to evaluate the effects of magnetic field on cellular activity of MC3T3-El cells. The celular activity was monitored by alkaline phosphatase and DNA synthetic activity in control, static magnetic field and pulsed electromagnetic field groups. A static magnetic field was applied to the cell by placing one, two, three, four, and five samarium-cobalt magnets above and below each cell plate for 24hours per day. A pulsed electromagnetic field with a frequency of 100 herz was applied for 10 hours per day. After 10 days of magnetic field exposure, there were increase of alkaline phosphatase activity in static magnetic field groups consisted of one, two and three magnetic groups, Alkaline phosphatase activities were not significantly increased in four and five magnetic groups, Application of pulsed electromagnetic field did not result in significant increase in alkaline phosphatase activity compared to control. DNA synthetic activity in both static and pulsed electromagnetic field group were not significantly different from that in control group, The result of this study suggest that magnetic field could have effect on the metabolism of bone cells related to the cellular metabolic process,
Alkaline Phosphatase*
;
DNA*
;
Electromagnetic Fields*
;
Magnetic Fields*
;
Magnets*
;
Metabolism
9.Soft tissue osteochondroma: a case report.
Jae Yo HYUN ; Seong Bae KIM ; Seung Ki JUNG ; Se Young JANG ; Jae Hyung LEE ; Seung Jae SON ; Ick Soo KIM
The Journal of the Korean Orthopaedic Association 1992;27(3):830-833
No abstract available.
Osteochondroma*
10.A Clinical Study on the Hypotensive Effect of Captopril.
Cheon Mo SEONG ; Jae Yong LEE ; Chun Suk KYEONG ; Dong Chan KIM ; Su Young LEE ; Kye Heui LEE ; Sang Jeon CHOI ; In SON ; Seong Hoon PARK
Korean Circulation Journal 1990;20(4):819-826
Antihypertensive effect of angiotensin converting enzyme(ACE) inhibitor Captopril was studied in 34 cases of essential hypertension. A single oral dose of 50mg Captopril was administered daily and blood pressure was followed every 2 weeks. Diuretics were added to patients who responded inadequately after 2 weeks of Captopril single treatment. Alpha-blocker, beta-blocker or calcium channel-blocker was added to patients who responded inadequately after another 2 weeks of Captopril and diuretics combined treatment. In 5 cases, Captopril was raised to 100mg and further antihypertensives were added to unresponded 3 cases. The resuts were as follows; 1) In 15 patients, blood pressure dropped from 170.3+/-10.5mmHg/108.7+/-6.1mmHg to 148.3+/-4.4mmHg/93.3+/-3.7mmHg after 8 weeks of Captopril 50mg single therapy. 2) Hydrochlorothiazide 25mg was added to non-responders, and blood pressure dropped from 180+/-6.7mmHg/111.1+/-6.2mmHg to 155.0+/-15.0mmHg/106.2+/-8.7mmHg in 9 of 19 patients after 8 weeks of combined treatment. 3) Alpha-blocker, Beta-blocker or calcium channel blocker was added to 10 non-responders to Captopril-hyprochlorothiazide combination therapy, and blood pressure dropped from 189.0+/-27mmHg/116+/-10mmHg to 137.8+/-15.5mmHg/88.5+/-10.2mmHg after 8 weeks. 4) Increase of captopril from 50mg to 100mg in 5 random nonresponder cases of Captopril single treatment lowered blood pressure from 168.0+/-13.6mmHg/107.1+/-6.4mmHg to 161+/-15.2mmHg/99+/-8.8mmHg after 2 weeks. 5) Heart rate, and serum creatinine, electrolytes and lipid levels showed no significant interval change. 6) Six patients complained of dry cough and one patient complained of poor appetite but no other clinically significant complications were noted during Captopril treatment.
Angiotensins
;
Antihypertensive Agents
;
Appetite
;
Blood Pressure
;
Calcium
;
Calcium Channels
;
Captopril*
;
Cough
;
Creatinine
;
Diuretics
;
Electrolytes
;
Heart Rate
;
Humans
;
Hydrochlorothiazide
;
Hypertension